Revenue
385 thousand USD
2024 Q3 · USD
Exact inputs and evidence
- Revenue: 384763 USD Source
Market value is not computed: no listed ticker is recorded for this company.
15 filing records in this dataset, filed from 2021-12-22 to 2024-11-21. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-18; this is not a statement that none were filed.
385 thousand USD
2024 Q3 · USD
-416.21%
2024 Q3 · %
83.9 thousand USD
2024 Q3 · USD
152357 USD
47906664 shares
19.86% · 7.94 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
1.82 million USD
2023-10-01 – 2024-09-30
-7.19 million USD
2023-10-01 – 2024-09-30
-800 thousand USD
2023-10-01 – 2024-09-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-11-21.
Financial data available through: 2023-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 1.22 million
–
Current period
USD 1.5 million
–
1497779 − 1218882 = 278897 USD
1218882 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source1497779 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 10.73 million
–
Current period
−USD 11.1 million
–
-11103503 − -10725183 = -378320 USD
-10725183 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-11103503 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 4.04 million
–
Current period
−USD 3.69 million
–
-3686663 − -4037342 = 350679 USD
-4037342 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-3686663 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | 827266 | 8567044 Derived | -7739778 | 12313 Derived | -7752091 | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 1218882 | 9285053 Derived | -8066171 | 2659012 Derived | -10725183 | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 1497779 | 10070684 Derived | -8572905 | 2530598 Derived | -11103503 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Revenue | 827266 |
|
| 2022 | Revenue | 1218882 |
|
| 2023 | Revenue | 1497779 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | 47.3% |
|
| 2023 | Year over year | 22.9% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Operating margin | -935.6% |
|
| 2022 | Operating margin | -661.8% |
|
| 2023 | Operating margin | -572.4% |
|
| 2021 | Net margin | -937.1% |
|
| 2022 | Net margin | -879.9% |
|
| 2023 | Net margin | -741.3% |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Operating cash flow | -2754054 |
|
| 2022 | Operating cash flow | -4037342 |
|
| 2023 | Operating cash flow | -3686663 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Liabilities / assets | 31% |
|
| 2022 | Liabilities / assets | 155.9% |
|
| 2023 | Liabilities / assets | 767.3% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2021 | Current assets / current liabilities | 1.44× |
|
| 2022 | Current assets / current liabilities | 1.13× |
|
| 2023 | Current assets / current liabilities | 0.1× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2021 2021-01-01 – 2021-12-31 | −USD 7.75 million Exact valueExact value: -7752091 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.75 million Exact valueExact value: -2754054 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 10.73 million Exact valueExact value: -10725183 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.04 million Exact valueExact value: -4037342 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 11.1 million Exact valueExact value: -11103503 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.69 million Exact valueExact value: -3686663 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
15 filings · 954 latest values · 954 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001892025, 1892025, edgar:1892025
Also known as OPTIMUS HEALTHCARE SERVICES, INC., Optimus Healthcare Services, Inc.